Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00034021 · ClinicalTrials.gov registry record · Phase 2
Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00034021 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH).
The verdict
NCT00034021, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to provide the first empirical examination of the effects of Ginkgo biloba (GBE), sex therapy, and a combination of the two on subjective and physiological measures of sexual function in women who are experiencing sexual disorders secondary to antidepressants.
Interventions
- DRUG Ginkgo Biloba
- BEHAVIORAL Sex Therapy (genital focus)
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-06 |
| Est. Completion | 2004-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00034021
The ClinicalTrials.gov registry entry for NCT00034021 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ginkgo Biloba is the first listed.
NCT00034021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00034021 about?
NCT00034021 is a clinical study titled "Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction". The purpose of this study is to provide the first empirical examination of the effects of Ginkgo biloba (GBE), sex therapy, and a combination of the two on subjective and physiological measures of sexual function in women who are experiencing sexual disorders secondary to antidepressants.
What is the current status of trial NCT00034021?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-06. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00034021?
The interventions under investigation include: Ginkgo Biloba (DRUG), Sex Therapy (genital focus) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00034021?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.